v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)        
Revenue $ 1,087,695 $ 0 $ 2,950,348 $ 0
Cost of goods sold 793,714 0 1,956,473 0
Gross profit 293,981 0 993,875 0
Operating expenses:        
Research and development 1,034,446 239,199 1,722,882 699,413
Selling, general and administrative 4,693,158 3,707,311 17,976,882 11,319,465
Total operating expenses 5,727,604 3,946,510 19,699,764 12,018,878
Loss from operations (5,433,623) (3,946,510) (18,705,889) (12,018,878)
Other (expense) income:        
Foreign exchange transaction loss (131,247) 0 (129,443) (935)
Change in fair value of share liability 381,969 (279,425) 327,969 (109,040)
Change in fair value of convertible notes payable (2,692,073) 0 (5,220,599) 0
Interest income 602,181 3,452 657,899 4,946
Interest expense (90,966) 0 (173,832) 0
Total other expense (1,930,136) (275,973) (4,538,006) (105,029)
Loss before income tax expense (7,363,759) (4,222,483) (23,243,895) (12,123,907)
Income tax provision 8,370 0 42,220 0
Net loss before allocation to noncontrolling interests (7,355,389) (4,222,483) (23,201,675) (12,123,907)
Less: Net loss attributable to noncontrolling interests (84,150) 0 (49,426) 0
Net loss attributable to ASP Isotopes Inc. shareholders before deemed dividend on inducement warrant for common stock (7,271,239) (4,222,483) (23,152,249) (12,123,907)
Deemed dividend on inducement warrant for common stock 0 0 (2,779,659) 0
Net loss attributable to ASP Isotopes Inc. shareholders $ (7,271,239) $ (4,222,483) $ (25,931,908) $ (12,123,907)
Net loss per share, attributable to ASP Isotopes Inc. shareholders, basic $ (0.12) $ (0.14) $ (0.5) $ (0.4)
Net loss per share, attributable to ASP Isotopes Inc. shareholders, diluted $ (0.12) $ (0.14) $ (0.5) $ (0.4)
Weighted average shares of common stock outstanding, basic 61,532,172 31,147,749 51,779,067 29,954,321
Weighted average shares of common stock outstanding, diluted 61,532,172 31,147,749 51,779,067 29,954,321
Comprehensive loss:        
Net loss before allocation to noncontrolling interests $ (7,355,389) $ (4,222,483) $ (23,201,675) $ (12,123,907)
Foreign currency translation 1,297,026 (64,644) 1,516,717 (1,541,170)
Total comprehensive loss before allocation to noncontrolling interests (6,058,363) (4,287,127) (21,684,958) (13,665,077)
Less: Comprehensive (loss) income attributable to noncontrolling interests (18,430) 0 26,343 0
Total comprehensive loss $ (6,039,933) $ (4,287,127) $ (21,711,301) $ (13,665,077)

Source